STTK vs TECX: fair value comparison
Shattuck Labs, Inc. and Tectonic Therapeutic, Inc. · Updated 2026-10-19
STTK has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. TECX has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. Within Healthcare, STTK currently ranks higher by quality score.
| STTK | TECX | |
|---|---|---|
| Verdict | No estimate yet | No estimate yet |
| Last price | $5.42 | $20.65 |
| 12-month range | $1.84–$8.06 | $16.44–$37.93 |
| Rank by discount to fair value | — | — |
| Rank by quality score | #270 of 301 Healthcare | #271 of 301 Healthcare |
| Quality grade | F | F |
| Leverage | Low | Low |
| Margin trend | Expanding | — |
| Revenue growth | Declining | — |
| RSI zone | Neutral | Oversold |
| 50/200-day trend | Mixed | Mixed |
| 52-week position | The upper-middle quarter | The bottom quarter |
Full single-stock breakdowns: STTK fair value analysis · TECX fair value analysis